Companies / Eikon Therapeutics, Inc. / Activity
Activity — Eikon Therapeutics, Inc.
12 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | New | Common stock | $55.87M | +4.3M | 4,281,425 7.91% of shares | high |
| Q2 2026 as of | Merck & Co., Inc. 13F manager | New | Common stock | $21.75M | +1.7M | 1,666,666 3.08% of shares | medium |
| Q1 2026 as of | AllianceBernstein L.P. 13F manager | New | Common stock | $10.81M | +1.0M | 1,022,188 1.89% of shares | medium |
| Q1 2026 as of | Baker Bros. Advisors LP 13F manager | New | Common stock | $5.88M | +556K | 555,555 1.03% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | New | Common stock | $4.62M | +354K | 354,093 0.65% of shares | low |
| Q1 2026 as of | CPPIB Crestone Peak Resources Canada Inc. 13F manager | New | Common stock | $4.01M | +379K | 379,024 0.70% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | New | Common stock | $2.90M | +274K | 273,931 0.51% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common stock | $1.86M | +176K | 175,627 0.32% of shares | low |
| Q1 2026 as of | Blackstone Inc 13F manager | New | Common stock | $1.78M | +168K | 168,338 0.31% of shares | low |
| Q1 2026 as of | TD Asset Management Inc 13F manager | New | Common stock | $603.8K | +57K | 57,074 0.11% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common stock | $280.9K | +22K | 21,522 0.04% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $142.6K | +13K | 13,480 0.02% of shares | low |